Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Peritoneal Neoplasms 3Colorectal Neoplasms 3Appendiceal Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Liver Neoplasms 2Carcinoma, Hepatocellular 2Uterine Neoplasms 1Urothelial Carcinoma Ureter 1Unspecified Adult Solid Tumor, Protocol Specific 1Solid Neoplasm 1Peritoneal Diseases 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Necrosis 1Lung Metastases 1Leukemia, Myeloid, Acute 1Leukemia 1Gastrointestinal Neoplasms 1Dermatitis 1

Interventions

Cytarabine 146Azacitidine 99venetoclax 95Cyclophosphamide 70fludarabine 69Decitabine 63fludarabine phosphate 55Specimen Handling 35Filgrastim 35Daunorubicin 34Mitoxantrone 30Idarubicin 29Etoposide 27Injections 25Granulocyte Colony-Stimulating Factor 25Biopsy 24Busulfan 22Tacrolimus 21Clofarabine 21Mycophenolic Acid 18Melphalan 18Methotrexate 17Bortezomib 17Whole-Body Irradiation 16Stem Cell Transplantation 16Peripheral Blood Stem Cell Transplantation 16Vorinostat 15Gemtuzumab 15Lenalidomide 14decitabine and cedazuridine drug combination 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Myeloid, Acute × Mitomycin × Clear all
NCT00003003 2018-03-19

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
29 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡